Psilocybin and Neuroplasticity: How Mushrooms Rewire the Brain
About This Video
Overview of the neuroplasticity research following psilocybin — covering BDNF (brain-derived neurotrophic factor) elevation, dendritic spine growth observed in animal models, enhanced synaptic plasticity, and the inferred human neuroplasticity from neuroimaging studies.
The 2-4 week therapeutic window is a central concept: the period following a psilocybin session during which the brain appears more plastic — more capable of forming new neural patterns — than baseline. This is when behavioral therapy, ERP, or integration work is most productive. The video explains why this window exists mechanistically and what it means for treatment design.
The clinical research implication: psilocybin-assisted therapy is not just about the acute experience. The session opens a window; what happens during the window determines outcomes. This is why the Hopkins and MAPS protocols continue therapy in the weeks after the psilocybin session.
Key Takeaways
- Psilocybin elevates BDNF (brain-derived neurotrophic factor) and promotes dendritic spine growth in animal models.
- Post-psilocybin neuroplasticity is elevated for approximately 2-4 weeks in human neuroimaging studies.
- This 'therapeutic window' is when behavioral therapy and integration work is most effective.
- Combination of psilocybin + therapy outperforms either alone because the medicine opens the window for therapy.
- The mechanism is distinct from conventional antidepressants, which modulate neurotransmitter levels without the same plasticity effects.
Dive Deeper
Continue exploring this topic on LearnShrooms: